If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!

SNDX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 6.30%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $13,888,827.27

Syndax Pharmaceuticals Insider Trading History Chart

Syndax Pharmaceuticals Share Price & Price History

^$20.66

▼ -0.89 (-4.13%)

As of 03/30/2023 01:00 AM ET

Days: 30 | 90 | 365

The Safest Option in Trades!

From Tradewins | Ad

Click here now!

Syndax Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/13/2023	Briggs Morrison	Insider	Sell	52,854	$22.53	$1,190,800.62	17,836
2/15/2023	Peter Ordentlich	insider	Sell	25,000	$25.84	$646,000.00
2/6/2023	Briggs Morrison	Insider	Sell	52,854	$26.83	$1,418,072.82	17,836
2/6/2023	Michael A. Metzger	CEO	Sell	5,959	$27.64	$164,706.76	17,659
1/12/2023	Pierre Legault	Director	Sell	24,000	$26.74	$641,760.00	32,000
12/1/2022	Peter Ordentlich	Insider	Sell	7,800	$25.01	$195,078.00	265
10/6/2022	Keith Katkin	Director	Sell	29,899	$25.90	$774,384.10	32,000
10/6/2022	Michael A. Metzger	CEO	Sell	16,231	$25.29	$410,481.99	17,659
10/4/2022	Michael A. Metzger	CEO	Sell	1,280	$25.02	$32,025.60	17,659
10/3/2022	Keith Katkin	Director	Sell	180	$25.00	$4,500.00	32,000
9/30/2022	Keith Katkin	Director	Sell	3,561	$25.07	$89,274.27	32,000
9/30/2022	Michael A. Metzger	CEO	Sell	29,606	$25.02	$740,742.12	17,659
9/20/2022	Briggs Morrison	Insider	Sell	59,649	$23.25	$1,386,839.25	17,836
9/16/2022	Dennis Podlesak	Director	Sell	11,975	$23.43	$280,574.25	75,763
9/15/2022	Briggs Morrison	Insider	Sell	66,775	$24.20	$1,615,955.00	17,836
8/24/2022	Peter Ordentlich	Insider	Sell	25,000	$25.04	$626,000.00	265
7/25/2022	Michael A. Metzger	CEO	Sell	31,602	$21.06	$665,538.12	17,659
7/7/2022	Michael A. Metzger	CEO	Sell	100	$21.00	$2,100.00	17,659
7/1/2022	Briggs Morrison	Insider	Sell	62,292	$19.00	$1,183,548.00	17,836
4/4/2022	Briggs Morrison	Insider	Sell	3,128	$18.29	$57,211.12	17,836
4/1/2022	Briggs Morrison	Insider	Sell	101,045	$17.45	$1,763,235.25	17,836
2/1/2022	Alexander Nolte	CAO	Sell	968	$16.65	$16,117.20
2/1/2022	Peter Ordentlich	Insider	Sell	1,412	$16.65	$23,509.80
12/22/2021	Pierre Legault	Director	Sell	24,000	$22.01	$528,240.00
12/20/2021	Michael A. Metzger	COO	Sell	61,000	$20.29	$1,237,690.00
12/20/2021	Pierre Legault	Director	Sell	20,000	$21.01	$420,200.00
12/17/2021	Briggs Morrison	CEO	Sell	35,156	$20.00	$703,120.00
12/17/2021	Michael A. Metzger	COO	Sell	1,676	$19.02	$31,877.52
12/13/2021	Michael A. Metzger	COO	Sell	36,609	$19.05	$697,401.45
11/18/2021	Fabrice Egros	Director	Sell	14,030	$18.03	$252,960.90
10/25/2021	Michael A. Metzger	COO	Sell	44,704	$19.13	$855,187.52
9/27/2021	Michael A. Metzger	COO	Sell	24,437	$19.51	$476,765.87
9/21/2021	Michael A. Metzger	COO	Sell	4,808	$19.16	$92,121.28
9/20/2021	Briggs Morrison	CEO	Sell	50	$20.00	$1,000.00
9/17/2021	Briggs Morrison	CEO	Sell	70,262	$20.07	$1,410,158.34
4/26/2021	Michael L. Meyers	SVP	Buy	500	$15.46	$7,730.00	15,666
4/22/2021	Dennis Podlesak	Director	Buy	13,967	$14.11	$197,074.37	43,300
12/1/2020	Michael A. Metzger	COO	Sell	15,000	$22.97	$344,550.00	32,659
11/23/2020	Peter Ordentlich	Insider	Sell	29,972	$23.16	$694,151.52	24,288
11/4/2020	Michael A. Metzger	COO	Sell	100,000	$20.31	$2,031,000.00	117,659

The Safest Option in Trades!

From Tradewins | Ad

Click here now!

SEC Filings (Institutional Ownership Changes) for Syndax Pharmaceuticals (NASDAQ:SNDX)

99.11% of Syndax Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Syndax Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
3/23/2023	MetLife Investment Management LLC	27,927	$0.71M	0.0%	+3.3%	0.041%
2/16/2023	HealthCor Management L.P.	70,000	$1.78M	1.6%	-91.9%	0.116%
2/15/2023	MetLife Investment Management LLC	27,927	$0.71M	0.0%	+3.3%	0.046%
2/15/2023	Kiwi Wealth Investments Limited Partnership	31,586	$0.80M	0.1%	N/A	0.052%
2/15/2023	Sphera Funds Management LTD.	710,561	$18.08M	3.9%	-13.6%	1.180%
2/15/2023	State of Wisconsin Investment Board	53,447	$1.36M	0.0%	+15.7%	0.089%
2/15/2023	Susquehanna Fundamental Investments LLC	61,514	$1.57M	0.0%	+36.0%	0.102%
2/15/2023	Sandia Investment Management LP	5,000	$0.13M	0.0%	N/A	0.008%
2/15/2023	Schonfeld Strategic Advisors LLC	9,100	$0.23M	0.0%	N/A	0.015%
2/15/2023	Soleus Capital Management L.P.	220,000	$5.60M	0.8%	N/A	0.365%
2/15/2023	T. Rowe Price Investment Management Inc.	1,002,886	$25.52M	0.0%	+8.6%	1.665%
2/15/2023	Legal & General Group Plc	21,260	$0.54M	0.0%	+10.6%	0.035%
2/15/2023	Morgan Stanley	149,369	$3.80M	0.0%	-5.8%	0.248%
2/15/2023	Norges Bank	169,100	$4.30M	0.0%	N/A	0.281%
2/15/2023	E Fund Management Co. Ltd.	13,863	$0.35M	0.0%	+37.7%	0.023%
2/15/2023	EAM Global Investors LLC	52,101	$1.33M	0.3%	-32.0%	0.087%
2/15/2023	EAM Investors LLC	35,391	$0.90M	0.2%	-32.2%	0.059%
2/15/2023	Eversept Partners LP	1,620,713	$41.25M	3.8%	+33.8%	2.691%
2/15/2023	Fred Alger Management LLC	14,977	$0.38M	0.0%	+10.0%	0.025%
2/15/2023	Algert Global LLC	77,780	$1.98M	0.1%	+59.1%	0.129%
2/15/2023	Alps Advisors Inc.	45,406	$1.16M	0.0%	+47.2%	0.075%
2/15/2023	AQR Capital Management LLC	25,175	$0.64M	0.0%	+14.8%	0.042%
2/15/2023	Avidity Partners Management LP	5,861,000	$149.16M	3.2%	+4.9%	9.732%
2/15/2023	Avoro Capital Advisors LLC	2,650,000	$67.44M	1.0%	+19.3%	4.400%
2/15/2023	Braidwell LP	1,242,802	$31.63M	1.1%	N/A	2.064%
2/15/2023	Nantahala Capital Management LLC	975,705	$24.83M	1.6%	-30.6%	1.620%
2/14/2023	Point72 Asset Management L.P.	923,400	$23.50M	0.1%	N/A	1.533%
2/14/2023	Alyeska Investment Group L.P.	100,000	$2.55M	0.0%	N/A	0.166%
2/14/2023	Price T Rowe Associates Inc. MD	9,364	$0.24M	0.0%	+11.1%	0.016%
2/14/2023	683 Capital Management LLC	570,000	$14.51M	1.2%	-49.6%	0.946%
2/14/2023	Arrowstreet Capital Limited Partnership	10,590	$0.27M	0.0%	N/A	0.018%
2/13/2023	Gyon Technologies Capital Management LP	68,195	$1.74M	0.6%	+106.8%	0.113%
2/13/2023	Charles Schwab Investment Management Inc.	448,741	$11.42M	0.0%	+16.5%	0.745%
2/13/2023	Deutsche Bank AG	43,585	$1.11M	0.0%	+62.1%	0.072%
2/13/2023	Panagora Asset Management Inc.	179,085	$4.56M	0.0%	+160.3%	0.297%
2/13/2023	Foresite Capital Management IV LLC	875,000	$22.27M	9.5%	+26.8%	1.453%
2/13/2023	Wells Fargo & Company MN	5,075	$0.13M	0.0%	-28.2%	0.008%
2/13/2023	Barclays PLC	963,336	$24.52M	0.0%	+249.3%	1.600%
2/13/2023	Renaissance Technologies LLC	81,200	$2.07M	0.0%	N/A	0.135%
2/13/2023	The Manufacturers Life Insurance Company	20,551	$0.52M	0.0%	+2.6%	0.034%
2/13/2023	Credit Suisse AG	54,642	$1.39M	0.0%	+20.9%	0.091%
2/13/2023	Martingale Asset Management L P	46,315	$1.18M	0.0%	+1.5%	0.077%
2/13/2023	Geode Capital Management LLC	1,101,029	$28.02M	0.0%	+13.7%	1.828%
2/13/2023	American Century Companies Inc.	13,363	$0.34M	0.0%	-20.0%	0.022%
2/13/2023	JPMorgan Chase & Co.	538,126	$13.70M	0.0%	-12.7%	0.894%
2/10/2023	Bank of America Corp DE	267,712	$6.81M	0.0%	-11.4%	0.445%
2/10/2023	Sei Investments Co.	15,243	$0.39M	0.0%	-4.9%	0.025%
2/10/2023	Connor Clark & Lunn Investment Management Ltd.	10,532	$0.27M	0.0%	-70.6%	0.017%
2/10/2023	Victory Capital Management Inc.	21,904	$0.56M	0.0%	-21.9%	0.032%
2/10/2023	Tekla Capital Management LLC	117,717	$3M	0.1%	N/A	0.195%
2/10/2023	CoreCap Advisors LLC	5,723	$0.15M	0.0%	N/A	0.010%
2/10/2023	Lord Abbett & CO. LLC	335,996	$8.55M	0.0%	+0.3%	0.558%
2/9/2023	Mirae Asset Global Investments Co. Ltd.	25,447	$0.65M	0.0%	+8.3%	0.042%
2/9/2023	Jennison Associates LLC	2,302,246	$58.59M	0.1%	+39.5%	3.823%
2/9/2023	Victory Capital Management Inc.	17,743	$0.49M	0.0%	-36.8%	0.029%
2/9/2023	Dimensional Fund Advisors LP	1,266,129	$32.22M	0.0%	+12.8%	2.102%
2/9/2023	Principal Financial Group Inc.	27,318	$0.70M	0.0%	+126.9%	0.045%
2/9/2023	Citigroup Inc.	265,933	$6.77M	0.0%	-49.9%	0.442%
2/8/2023	Raymond James Financial Services Advisors Inc.	34,597	$0.88M	0.0%	N/A	0.057%
2/8/2023	UBS Group AG	172,785	$4.40M	0.0%	-39.5%	0.287%
2/8/2023	Swiss National Bank	129,400	$3.29M	0.0%	+14.2%	0.215%
2/8/2023	Russell Investments Group Ltd.	39,595	$1.01M	0.0%	N/A	0.066%
2/8/2023	Arizona State Retirement System	13,567	$0.35M	0.0%	+4.4%	0.023%
2/7/2023	State Board of Administration of Florida Retirement System	13,218	$0.34M	0.0%	+3.2%	0.022%
2/3/2023	Frazier Life Sciences Management L.P.	3,708,838	$94.39M	5.9%	+8.7%	6.159%
2/2/2023	SG Americas Securities LLC	6,899	$0.18M	0.0%	-69.8%	0.011%
2/2/2023	Principle Wealth Partners LLC	15,000	$0.38M	0.0%	N/A	0.025%
2/2/2023	ProShare Advisors LLC	11,827	$0.30M	0.0%	+11.3%	0.020%
2/1/2023	Zurcher Kantonalbank Zurich Cantonalbank	9,732	$0.25M	0.0%	+15.0%	0.016%
1/31/2023	Keybank National Association OH	9,307	$0.24M	0.0%	N/A	0.015%
1/30/2023	Psagot Value Holdings Ltd. Israel	5,000	$0.13M	0.0%	N/A	0.008%
1/26/2023	Inspire Investing LLC	9,378	$0.24M	0.0%	N/A	0.016%
1/26/2023	Calamos Advisors LLC	12,937	$0.33M	0.0%	N/A	0.021%
1/24/2023	Ziegler Capital Management LLC	33,687	$0.86M	0.0%	-19.0%	0.056%
1/12/2023	Assenagon Asset Management S.A.	10,015	$0.26M	0.0%	-50.2%	0.017%
12/8/2022	Bank of New York Mellon Corp	189,194	$4.55M	0.0%	+13.2%	0.314%
11/22/2022	Teachers Retirement System of The State of Kentucky	40,734	$0.98M	0.0%	N/A	0.068%
11/21/2022	California State Teachers Retirement System	62,140	$1.49M	0.0%	+2.8%	0.103%
11/16/2022	Fred Alger Management LLC	13,618	$0.33M	0.0%	N/A	0.023%
11/16/2022	BNP Paribas Arbitrage SNC	66,277	$1.59M	0.0%	+425.5%	0.110%
11/15/2022	Alliancebernstein L.P.	108,820	$2.62M	0.0%	+156.7%	0.181%
11/15/2022	State Street Corp	2,617,437	$62.90M	0.0%	+7.5%	4.346%
11/15/2022	Algert Global LLC	48,900	$1.18M	0.1%	-10.6%	0.081%
11/15/2022	Two Sigma Advisers LP	371,752	$8.93M	0.0%	+5.4%	0.617%
11/15/2022	UBS Asset Management Americas Inc.	43,303	$1.04M	0.0%	-6.4%	0.072%
11/15/2022	Vanguard Group Inc.	2,802,299	$67.34M	0.0%	+0.8%	4.653%
11/15/2022	PFM Health Sciences LP	1,289,073	$30.98M	1.1%	+122.0%	2.140%
11/15/2022	Price T Rowe Associates Inc. MD	8,429	$0.20M	0.0%	N/A	0.014%
11/15/2022	Kynam Capital Management LP	2,272,915	$54.62M	11.5%	-9.5%	3.774%
11/15/2022	Lord Abbett & CO. LLC	334,963	$8.05M	0.0%	+6.4%	0.556%
11/15/2022	Martingale Asset Management L P	45,636	$1.10M	0.0%	+350.7%	0.076%
11/15/2022	Ensign Peak Advisors Inc	211,368	$5.08M	0.0%	+67.5%	0.351%
11/15/2022	Foresite Capital Management IV LLC	690,000	$16.58M	5.3%	N/A	1.146%
11/15/2022	BVF Inc. IL	1,798,085	$43.21M	1.8%	-23.7%	2.986%
11/15/2022	Bank of New York Mellon Corp	189,194	$4.55M	0.0%	+13.2%	0.314%
11/15/2022	Bayesian Capital Management LP	10,877	$0.26M	0.1%	N/A	0.018%
11/15/2022	BlackRock Inc.	4,139,617	$99.48M	0.0%	+9.1%	6.874%
11/15/2022	Caxton Associates LP	25,576	$0.62M	0.1%	N/A	0.042%
11/15/2022	Commodore Capital LP	738,110	$17.74M	2.9%	N/A	1.226%
11/14/2022	Macquarie Group Ltd.	180,000	$4.35M	0.0%	-0.5%	0.299%

Data available starting January 2016

Syndax Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company engaged in the development of cancer therapies. Its product candidates include SNDX-5613 and SNDX-6352. The company was founded by Richard A. Heyman, Eckard Weber, Peter Ordentlich, Ronald M. Evans and Michael Downes on October 11, 2005 and is headquartered in Waltham, MA.

Today's Range

Now: $20.66

$20.01

$21.88

50 Day Range

MA: $24.81

$20.66

$28.98

52 Week Range

Now: $20.66

$13.27

$29.86

Volume

889,205 shs

Average Volume

780,447 shs

Market Capitalization

$1.41 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.04

Who are the company insiders with the largest holdings of Syndax Pharmaceuticals?: Syndax Pharmaceuticals' top insider investors include:
Dennis Podlesak (Director)
Keith Katkin (Director)
Pierre Legault (Director)
Briggs Morrison (Insider)
Michael A Metzger (CEO)
Michael L Meyers (SVP)
Peter Ordentlich (Insider)
Alexander Nolte (CAO)
Briggs Morrison (CEO)
Fabrice Egros (Director)
Michael A Metzger (COO)
Learn More about top insider investors at Syndax Pharmaceuticals.
Who are the major institutional investors of Syndax Pharmaceuticals?: Syndax Pharmaceuticals' top institutional investors include:
Avidity Partners Management LP — 9.73%
Frazier Life Sciences Management L.P. — 6.16%
Avoro Capital Advisors LLC — 4.40%
Jennison Associates LLC — 3.82%
Eversept Partners LP — 2.69%
Dimensional Fund Advisors LP — 2.10%
Learn More about top institutional investors of Syndax Pharmaceuticals stock.
Which major investors are selling Syndax Pharmaceuticals stock?: During the previous quarter, SNDX stock was sold by these institutional investors:
HealthCor Management L.P.
683 Capital Management LLC
Nantahala Capital Management LLC
Citigroup Inc.
UBS Group AG
Sphera Funds Management LTD.
JPMorgan Chase & Co.
Bank of America Corp DE
During the previous year, company insiders that have sold Syndax Pharmaceuticals company stock include:
Dennis Podlesak (Director)
Keith Katkin (Director)
Pierre Legault (Director)
Briggs Morrison (Insider)
Michael A Metzger (CEO)
Michael L Meyers (SVP)
Learn More investors selling Syndax Pharmaceuticals stock.
Which major investors are buying Syndax Pharmaceuticals stock?: During the previous quarter, SNDX stock was bought by institutional investors including:
Braidwell LP
Point72 Asset Management L.P.
Barclays PLC
Jennison Associates LLC
Avoro Capital Advisors LLC
Eversept Partners LP
Frazier Life Sciences Management L.P.
Avidity Partners Management LP
During the previous year, these company insiders have bought Syndax Pharmaceuticals stock:
Dennis Podlesak (Director)
Keith Katkin (Director)
Learn More investors buying Syndax Pharmaceuticals stock.

The Safest Option in Trades!

From Tradewins | Ad

Click here now!

SNDX Insider Trading

Syndax Pharmaceuticals Insider Trading History Chart

Syndax Pharmaceuticals Share Price & Price History

Syndax Pharmaceuticals Insider Trading History

SEC Filings (Institutional Ownership Changes) for Syndax Pharmaceuticals (NASDAQ:SNDX)

Institutional Buying and Selling by Quarter

Syndax Pharmaceuticals Institutional Trading History

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Who are the company insiders with the largest holdings of Syndax Pharmaceuticals?

Who are the major institutional investors of Syndax Pharmaceuticals?

Which major investors are selling Syndax Pharmaceuticals stock?

Which major investors are buying Syndax Pharmaceuticals stock?